Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glycerophosphodiester phosphodiesterase domain-containing protein 4 (GDPD4) is an enzyme encoded by the GDPD4 gene in humans. It contains a glycerophosphodiester phosphodiesterase domain and is predicted to be involved in lipid and glycerol metabolism, likely functioning in phosphoric diester hydrolase activity and acting at the membrane. GDPD4 has been associated with diseases such as Achromatopsia 4 and Van Maldergem Syndrome. This protein belongs to the enzyme class and contains a TIM barrel α/β fold structure characteristic of the glycerophosphodiester phosphodiesterase protein family[1][2][3][4][7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycerophosphodiester phosphodiesterase domain-containing protein 4 (GDPD4).